APA (7th ed.) Citation

V, R., BP, K., WL, H., N, N., L, P., D, G., . . . B, J. (2026). Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development. Med (New York, N.Y.), 7(1), 100925. https://doi.org/10.1016/j.medj.2025.100925

Chicago Style (17th ed.) Citation

V, Roy, et al. "Epstein-Barr-virus-specific Functional Antibody Signatures in the Context of Nasopharyngeal Carcinoma Development." Med (New York, N.Y.) 7, no. 1 (2026): 100925. https://doi.org/10.1016/j.medj.2025.100925.

MLA (9th ed.) Citation

V, Roy, et al. "Epstein-Barr-virus-specific Functional Antibody Signatures in the Context of Nasopharyngeal Carcinoma Development." Med (New York, N.Y.), vol. 7, no. 1, 2026, p. 100925, https://doi.org/10.1016/j.medj.2025.100925.